How valuable are multiple treatment comparison methods in evidence-based health-care evaluation

Value in Health

Volumn 14, Issue 2, 2011, Pages 371-380

  Cooper, Nicola J ^a   Peters, Jaime ^b   Lai, Monica C W ^a   Juni, Peter ^d   Wandel, Simon ^d   Palmer, Steve ^e   Paulden, Mike ^e   Conti, Stefano ^f   Welton, Nicky J ^g   Abrams, Keith R ^a   Bujkiewicz, Sylwia ^a   Spiegelhalter, David ^c   Sutton, Alex J ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF EXETER   (United Kingdom)

^c MRC BIOSTATISTICS UNIT   (United Kingdom)

^d UNIVERSITY OF BERN   (Switzerland)

^e UNIVERSITY OF YORK   (United Kingdom)

^f PUBLIC HEALTH ENGLAND   (United Kingdom)

^g UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Decision models; Evidence synthesis; Meta analysis; Mixed treatment comparisons; Network meta analysis

Indexed keywords

ACETYLSALICYLIC ACID; OSELTAMIVIR; SIALIDASE INHIBITOR; WARFARIN; ZANAMIVIR;

ACCURACY; ARTICLE; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DRUG ELUTING STENT; EVALUATION; EVIDENCE BASED MEDICINE; HEART ATRIUM FIBRILLATION; HUMAN; INFLUENZA; INTERMETHOD COMPARISON; META ANALYSIS (TOPIC); PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); STROKE;

EID: 79959598016     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2010.09.001     Document Type: Article

References (28)

1. Sutton AJ, Abrams KR, Jones DR, et al. Methods For Meta- Analysis In Medical Research. Chichester, England: John Wiley & Sons, Ltd, 2000.
2. Lumley T. Network meta-analysis for indirect treatment comparisons. Stat Med 2002;21:2313-24.
3. Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med 2004;23:3105-24. (Pubitemid 39334902)
4. Caldwell DM, Ades AE, Higgins JPT. Simultaneous comparison of multiple treatments: Combining direct and indirect evidence. BMJ 2005;331:897-900. (Pubitemid 41502718)
5. O'Regan C, Ghement I, Eyawo O, et al. Incorporating multiple interventions in meta-analysis: An evaluation of the mixed treatment comparison with the adjusted indirect comparison. Trials 2009;10:86.
6. Guide to the Methods of Technology Appraisal. London: National Institute for Health and Clinical Excellence, 2008.
7. Wells GA, Sultan SA, Chen L, et al. Indirect Evidence: Indirect Treatment Comparisons In Meta-Analysis. Ottawa: Canadian Agency for Drugs and Technologies in Health, 2009.
8. Report of the Indirect Comparisons Working Group to the Pharmaceutical Benefits Advisory Committee: Assessing indirect comparisons. Pharmaceutical Benefits Advisory Committee, Canberra, Australia, 2009.
9. Sutton AJ, Ades AE, Cooper NJ, Abrams KR. Use of indirect and mixed treatment comparisons for technology assessment. Pharmacoeconomics 2008;26:753-67.
10. Hawkins N, Scott DA, Woods B. How far do you go? Efficient searching for indirect evidence. Med Decis Making 2009;29: 273-81.
11. Spiegelhalter D, Thomas A, Best N, Lunn D. WinBUGS User Manual: Version 1.4. Cambridge, England: MRC Biostatistics Unit, 2003.
12. Lu G, Ades AE, Sutton AJ, et al. Meta-analysis of mixed treatment comparisons at multiple follow-up times. Stat Med 2007;26:3681-99. (Pubitemid 47307743)
13. Welton NJ, Cooper NJ, Ades AE, et al. Mixed treatment comparison with multiple outcomes reported inconsistently across trials: Evaluation of antivirals for treatment of influenza A and B. Stat Med 2008;27:5620-39.
14. Cooper NJ, Sutton AJ, Abrams KR, et al. Comprehensive decision analytical modelling in economic evaluation: A Bayesian approach. Health Econ 2004;13:203-26.
15. Singer DE. Overview of the randomised controlled trials to prevent stroke in atrial fibrillation. Ann Epidemiol 1993;3:563-7. (Pubitemid 23339599)
16. Green CJ, Hadorn DC, Bassett K, Kazanjian A. Anti-coagulation in chronic nonvalvular atrial fibrillation: A critical appraisal and meta-analysis. Can J Cardiol 1997;13:811-15. (Pubitemid 27460415)
17. Hart RG, Benavente O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis. Ann Intern Med 1999;131:492-501. (Pubitemid 29482392)
18. Segal JB, McNamara RL, Miller MR, et al. Prevention of thromboembolism in atrial fibrillation: A meta-analysis of trials of anti-coagulants and antiplatelet drugs. J Gen Intern Med 2000;15:56-67. (Pubitemid 30060940)
19. Taylor FC, Ebrahim S. Systematic review of long term anticoagulation or antiplatelet treatment in patients with non-rheumatic atrial fibrillation. BMJ 2001;322:321-6. (Pubitemid 32150728)
20. van Walraven C, Hart RG, Singer DE, et al. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: An individual patient meta-analysis. JAMA 2002;288:2441-8. (Pubitemid 35340540)
21. Cooper NJ, Sutton AJ, Lu G, Khunti K. Mixed comparison of stroke prevention treatments in individuals with nonrheumatic atrial fibrillation. Arch Intern Med 2006;166:1269-75. (Pubitemid 43967578)
22. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Arch Intern Med 2007; 146:857-67. (Pubitemid 351650486)
23. Hill RA, Boland A, Dickson R, et al. Drug-eluting stents: A systematic review and economic evaluation. Health Technol Assess 2007; report 11.
24. Stettler C, Allemann S, Wandel S, et al. Drug eluting and bare metal stents in people with and without diabetes: Collaborative network meta-analysis. BMJ 2008;337:a1331.
25. Burch J, Paulden M, Conti S, et al. Antiviral drugs for the treatment of influenza: A systematic review and economic evaluation. NICE Appraisal 2009;168.
26. Turner D, Wailoo A, Nicholson K, et al. Systematic review and economic decision modelling for the prevention and treatment of influenza A and B. Health Technol Assess 2003; report 7.
27. Collett D. Modelling Survival Data In Medical Research (2nd ed.). New York: Chapman and Hall/CRC, 2003.
28. Bucher HC, Guyatt GH, Hutchinson A, Eccles M. The results of direct and indirect treatment comparisons in metaanalysis of randomised controlled trials. J Clin Epidemiol 1997;50:683-9.